Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
Daniels C, Krack P, Volkmann J, Raethjen J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G, Witt K.
Daniels C, et al. Among authors: raethjen j.
Mov Disord. 2011 Dec;26(14):2516-21. doi: 10.1002/mds.23907. Epub 2011 Aug 25.
Mov Disord. 2011.
PMID: 22170276
Clinical Trial.